Daratumumab in Combination with Carfilzomib, Lenalidomide, and Dex (KRd) in Pts with NDMM

Daratumumab (DARA) in Combination with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) in Patients with Newly Diagnosed Multiple Myeloma (MMY1001): Updated Results from an Open-Label, Phase 1b Stud... Author: InternationalMyelomaFoundation Added: 01/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts